Everest Organics Limited
BSE: EVERESTO
Prev Close
316.55
Open Price
324
Volume
9,846
Today Low / High
320 / 332.35
52 WK Low / High
210.95 / 477
Range
316 - 349
The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 332.35, reflecting a change of 15.8 (4.99131%). The expected target range on the BSE is 316 - 349. The stock is showing an upward trend on the BSE, making it an appealing option for investors looking for growth in their portfolio.
Everest Organics Limited Graph
Everest Organics Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Everest Organics Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 332.35, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 332.35 | 335.67 | 302.11 - 369.24 |
| 339.00 | 271.20 - 406.80 | ||
| 342.32 | 239.62 - 445.02 | ||
| Bearish Scenario | 332.35 | 329.03 | 296.12 - 361.93 |
| 325.70 | 260.56 - 390.84 | ||
| 322.38 | 225.67 - 419.09 |
Overview of Everest Organics Limited
ISIN
INE334C01029
Industry
Medical - Distribution
Vol.Avg
3,980
Market Cap
3,081,636,696
Last Dividend
0
Official Website
IPO Date
DCF Diff
440.61
DCF
-121
Financial Ratios Every Investor Needs
Stock Dividend of EVERESTO
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2022-09-15 | September 15, 22 | 0.5 | 0.5 | 2022-09-16 | 2022-10-24 | |
| 2021-09-08 | September 08, 21 | 1 | 1 | 2021-09-10 | 2021-10-18 | |
| 2021-02-17 | February 17, 21 | 0.5 | 0.5 | 2021-02-18 | 2021-03-10 | |
| 2020-09-01 | September 01, 20 | 1 | 1 | 2020-09-02 | 2020-10-08 | |
| 2019-09-03 | September 03, 19 | 1 | 1 | 2019-09-04 | 2019-10-10 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 159.48 Cr | 98.54 Cr | 60.94 Cr | 0.3821 | 0.00 Cr | 0.00 Cr | 1.26 Cr | -1.29 Cr | -1.61 | 7.91 Cr | -0.0081 |
| 2024-03-31 | 197.24 Cr | 154.62 Cr | 42.62 Cr | 0.2161 | 0.00 Cr | 3.93 Cr | 5.19 Cr | 0.14 Cr | 0.17 | 11.25 Cr | 0.0007 |
| 2023-03-31 | 183.05 Cr | 174.29 Cr | 8.75 Cr | 0.0478 | 0.52 Cr | 10.56 Cr | -3.50 Cr | -0.18 Cr | -0.23 | 7.87 Cr | -0.0010 |
| 2022-03-31 | 200.05 Cr | 184.87 Cr | 15.17 Cr | 0.0758 | 2.28 Cr | 4.61 Cr | 2.74 Cr | 1.14 Cr | 1.43 | 8.64 Cr | 0.0057 |
| 2021-03-31 | 181.57 Cr | 151.18 Cr | 30.39 Cr | 0.1674 | 2.22 Cr | 4.12 Cr | 19.52 Cr | 13.72 Cr | 17.14 | 23.90 Cr | 0.0755 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 6.09 Cr | 224.48 Cr | 154.54 Cr | 69.9469 Cr | 47.87 Cr | 41.78 Cr | 45.25 Cr | 69.71 Cr | 0.00 Cr | 0.00 Cr | 1.44 Cr | 139.9244 Cr |
| 2024-03-31 | 0.83 Cr | 226.72 Cr | 180.88 Cr | 45.8399 Cr | 57.79 Cr | 56.96 Cr | 43.76 Cr | 71.67 Cr | 0.00 Cr | 0.00 Cr | 0.08 Cr | 160.1012 Cr |
| 2023-03-31 | 0.83 Cr | 201.85 Cr | 155.63 Cr | 46.2149 Cr | 51.05 Cr | 50.22 Cr | 47.28 Cr | 63.96 Cr | 0.02 Cr | 0.00 Cr | 0.32 Cr | 137.5823 Cr |
| 2022-03-31 | 0.65 Cr | 178.00 Cr | 131.20 Cr | 46.7970 Cr | 38.78 Cr | 38.13 Cr | 42.55 Cr | 57.00 Cr | 0.29 Cr | 0.00 Cr | 0.34 Cr | 112.5623 Cr |
| 2021-03-31 | 1.66 Cr | 135.38 Cr | 88.80 Cr | 46.5756 Cr | 22.90 Cr | 21.24 Cr | 34.24 Cr | 43.64 Cr | 3.02 Cr | 0.00 Cr | 0.29 Cr | 77.3608 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | -5.3769 Cr | -5.1693 Cr | 16.3648 Cr | -10.8034 Cr | 5.8186 Cr | 6.0920 Cr | -3.5771 Cr | -3.2426 Cr | -5.4453 Cr | 0.0000 Cr | -1.4834 Cr |
| 2024-03-31 | 16.4201 Cr | -13.3228 Cr | -3.0986 Cr | 3.3268 Cr | -0.5554 Cr | 0.2734 Cr | -13.0933 Cr | 0.1392 Cr | 2.3679 Cr | 0.0000 Cr | 2.9716 Cr |
| 2023-03-31 | 15.1409 Cr | -15.2304 Cr | 0.2645 Cr | 1.4206 Cr | 0.1773 Cr | 0.8288 Cr | -13.7203 Cr | -0.1822 Cr | 0.6645 Cr | -0.4000 Cr | -5.2454 Cr |
| 2022-03-31 | 10.6886 Cr | -16.8700 Cr | 5.1712 Cr | -6.4661 Cr | -1.0102 Cr | 0.6515 Cr | -17.1547 Cr | 1.1437 Cr | 5.1712 Cr | -0.8000 Cr | -8.5666 Cr |
| 2021-03-31 | 10.3861 Cr | -11.9275 Cr | 1.2019 Cr | 3.5366 Cr | -0.3395 Cr | 1.6617 Cr | -6.8495 Cr | 13.7150 Cr | 1.2019 Cr | -1.2000 Cr | -5.5246 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 40.93 Cr | 24.89 Cr | 16.04 Cr | 0.3919 | 1.88 Cr | 2.91 Cr | 3.63 | 3.65 Cr | 0.0712 |
| 2024-12-31 | 42.05 Cr | 25.34 Cr | 16.71 Cr | 0.3973 | 2.55 Cr | 1.14 Cr | 1.42 | 4.02 Cr | 0.0271 |
| 2024-09-30 | 44.05 Cr | 26.07 Cr | 17.98 Cr | 0.4082 | 1.96 Cr | 0.74 Cr | 0.93 | 3.57 Cr | 0.0168 |
| 2024-06-30 | 32.45 Cr | 28.11 Cr | 4.34 Cr | 0.1337 | -5.13 Cr | -6.09 Cr | -7.61 | -3.33 Cr | -0.1877 |
| 2024-03-31 | 52.62 Cr | 39.78 Cr | 12.83 Cr | 0.2439 | 1.11 Cr | 0.06 Cr | 0.07 | 3.26 Cr | 0.0011 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 6.09 Cr | 1.16 Cr | 7.25 Cr | 88.43 Cr | 45.25 Cr | 147.90 Cr | 69.71 Cr | 224.48 Cr | 154.54 Cr |
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 0.79 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -40.49 Cr |
| 2024-09-30 | 0.24 Cr | 0.76 Cr | 1.00 Cr | 91.22 Cr | 45.88 Cr | 143.92 Cr | 70.59 Cr | 219.86 Cr | 179.37 Cr |
| 2024-06-30 | 0.87 Cr | 0.72 Cr | 0.87 Cr | 98.29 Cr | 46.55 Cr | 152.57 Cr | 71.27 Cr | 228.94 Cr | 189.19 Cr |
| 2024-03-31 | 0.83 Cr | 0.76 Cr | 0.83 Cr | 100.09 Cr | 43.76 Cr | 149.98 Cr | 71.67 Cr | 226.72 Cr | 180.88 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2024-12-31 | 1.14 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | 0.74 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | -6.09 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-03-31 | 0.06 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2023-12-31 | 0.02 Cr | 0.02 Cr | 0.00 Cr | 0.00 Cr | 0.11 Cr | 0.32 Cr | 0.21 Cr | 0.00 Cr | 0.02 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| No split history data available. | ||
Similar Stocks: Medical - Distribution
No stocks found in this industry.
Key Executives
Gender: Not Specified
Year Born: 1979
Gender: Not Specified
Year Born: 1977
Gender: male
Year Born: 1979
Gender: male
Year Born: 1966
FAQs about Everest Organics Limited
The CEO is Sirisha Sri Kakarlapudi.
The current price is ₹317.35.
The range is ₹210.95-477.
The market capitalization is ₹308.16 crores.
The P/E ratio is -195.71.
The company operates in the Healthcare sector.
Overview of Everest Organics Limited (ISIN: INE334C01029) is a leading Medical - Distribution in India. With a market capitalization of ₹308.16 crores and an average daily volume of 3,980 shares, it operates in the Medical - Distribution. The company last declared a dividend of ₹0.